Alibaba Health Information Technology Limited (ALBHF)
OTCMKTS · Delayed Price · Currency is USD
0.8067
+0.0407 (5.32%)
Oct 27, 2025, 2:57 PM EDT
ALBHF Revenue
In the fiscal year ending March 31, 2025, Alibaba Health Information Technology had annual revenue of 30.60B CNY with 13.22% growth. Alibaba Health Information Technology had revenue of 16.32B in the half year ending March 31, 2025, with 6.96% growth.
Revenue
30.60B CNY
Revenue Growth
+13.22%
P/S Ratio
2.98
Revenue / Employee
22.43M CNY
Employees
1,364
Market Cap
12.55B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 30.60B | 3.57B | 13.22% |
| Mar 31, 2024 | 27.03B | 263.54M | 0.98% |
| Mar 31, 2023 | 26.76B | 6.19B | 30.06% |
| Mar 31, 2022 | 20.58B | 5.06B | 32.60% |
| Mar 31, 2021 | 15.52B | 5.92B | 61.71% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Alibaba Health Information Technology News
- 4 months ago - Alibaba seeks US$1.5 billion from exchangeable bonds for cloud, e-commerce push - South China Morning Post
- 8 months ago - Alibaba Health: AI-Driven Growth And Digital Healthcare Leadership - Seeking Alpha
- 4 years ago - Apps in Beijing's crosshairs as crackdown heats up - Reuters
- 5 years ago - China's digital health care start-ups get a boost from the coronavirus, Beijing and investors - CNBC
- 5 years ago - Alibaba Health raises $1.3 billion in Hong Kong's biggest secondary share sale in 5 years - Reuters